Intended for healthcare professionals

Rapid response to:


Drugs for pre-osteoporosis: prevention or disease mongering?

BMJ 2008; 336 doi: (Published 17 January 2008) Cite this as: BMJ 2008;336:126

Rapid Response:

More disease mongering?

Could people stop pretending that the pharma industry doesn't
undertake "market shaping" for its products prior to launch, and even
after launch. There are no end of "medical education" agencies that will
openly admit this is what the do for their clients.

Competing interests:
None declared

Competing interests: No competing interests

20 February 2008
Onisillos Sekkides
London, NW1